Replies to post #222433 on Biotech Values

[DewDiligence]

RVNC—A press release on the top-line SAKURA-3* results is expected in the next couple of weeks. ct.gov shows the trial completed as of 10/17/18 (https://www.clinicaltrials.gov/ct2/show/NCT03004248 ).

*2,700-patient open-label safety study including repeated RT002 injections for some patients.